A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors - Top-Institutions - MDSpire

A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors

  • By

  • Lorcan Ruane

  • Sivatharshini Ramalingam

  • Alexander R Lyon

  • January 30, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Cardio-Oncology
    • Oncology
    • Cardiology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Cardio-Oncology
    • Oncology
    • Cardiology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cardio-Oncology
    • Oncology
    • Cardiology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardio-Oncology

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Cardio-Oncology
    • Cardiology
    • Oncology

Original Source(s)

A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors

  • by Lorcan Ruane, Sivatharshini Ramalingam, Alexander R Lyon

  • January 30, 2026

Related Content

Clinical Decision Support System, Antihypertensive Treatment Intensification, and Blood Pressure Control: A

The role of albumin–globulin ratio in peripheral arterial disease among hypertensive adults: evidence from a large-scale multicenter study

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure